HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

Cardiovascular diseases are the leading cause of death globally and in Brazil. The provision of quality healthcare faces ...

Given this, the prompt recognition and stratification of individuals at elevated risk are critical ... (2) Commonly known as the “saddleback type,” the Type 2 ECG pattern is defined by an ST segment ...

It’s now made of Titanium. The firm claims the “enhanced sensors” add things like ECG and Atrial Fibrillation detection, which is FDA-certified. Circular Ring 2 also aims to solve connectivity woes ...